SASKATOON, Saskatchewan–(BUSINESS WIRE)–CanniMed Therapeutics Inc. (TSX: CMED) (“CanniMed”) is pleased to announce that it has entered into a definitive agreement with PharmaChoice for supply of CanniMed’s herbal, oils and oil derivative cannabis products to PharmaChoice’s over 750 … Read More
The post CanniMed Therapeutics Inc. Announces Medical Cannabis Supply Agreement with PharmaChoice appeared first on Dagga Magazine.